all-antibody

Malnutrition-Inflammation Complex Syndrome In Dialysis Patients

Robust affiliation between malnutrition, irritation, and atherosclerosis in power renal failure.

Background

Atheroscleroticcardiovascular illness and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

METHODS

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion. The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

 

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

all-antibody
all-antibody

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

GPR61 Antibody
44933-50ul 50ul
EUR 224.4

GPR61 Antibody
DF2755 200ul
EUR 420

GPR61 Antibody
DF2755-100ul 100ul
EUR 280

GPR61 Antibody
DF2755-200ul 200ul
EUR 350

GPR61 Antibody
DF2810 200ul
EUR 420

GPR61 Antibody
DF2810-100ul 100ul
EUR 280

GPR61 Antibody
DF2810-200ul 200ul
EUR 350

GPR61 Antibody
ABD2755 100ug
EUR 325

GPR61 Antibody
ABD2810 100ug
EUR 325

GPR61 antibody
MBS535608-005mg 0.05mg
EUR 1125

GPR61 antibody
MBS535608-5x005mg 5x0.05mg
EUR 4905

GPR61 antibody
MBS535619-005mg 0.05mg
EUR 1125

GPR61 antibody
MBS535619-5x005mg 5x0.05mg
EUR 4905

GPR61 antibody
MBS535674-005mg 0.05mg
EUR 1125

GPR61 antibody
MBS535674-5x005mg 5x0.05mg
EUR 4905

GPR61 Antibody
MBS9604269-01mL 0.1mL
EUR 260

GPR61 Antibody
MBS9604269-02mL 0.2mL
EUR 305

GPR61 Antibody
MBS9604269-5x02mL 5x0.2mL
EUR 1220

GPR61 Antibody
MBS9604324-01mL 0.1mL
EUR 260

GPR61 Antibody
MBS9604324-02mL 0.2mL
EUR 305

GPR61 Antibody
MBS9604324-5x02mL 5x0.2mL
EUR 1220

GPR61 Antibody
MBS9418327-005mL 0.05mL
EUR 245

GPR61 Antibody
MBS9418327-01mL 0.1mL
EUR 305

GPR61 Antibody
MBS9418327-5x01mL 5x0.1mL
EUR 1230

GPR61 Antibody
C43983-100ul 100μl
EUR 217
Description: GPR61 Rabbit Polyclonal Antibody

GPR61 Antibody
C43983-50ul 50μl
EUR 143.5
Description: GPR61 Rabbit Polyclonal Antibody

G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody
GWB-229204 0.05 mg Ask for price

G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody
GWB-1215F5 0.05 mg Ask for price

G Protein-Coupled Receptor GPR61 Rabbit anti-Human Polyclonal Antibody
GWB-A590FB 0.05 mg Ask for price

GPR61 Polyclonal Antibody
ABP58695-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody
ABP58695-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody
ABP58695-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of GPR61 from Human, Mouse. This GPR61 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPR61 protein at amino acid sequence of 190-270

GPR61 Polyclonal Antibody
E11-202531 100ug/100ul
EUR 225
Description: Available in various conjugation types.

GPR61 Conjugated Antibody
C44933 100ul
EUR 476.4

GPR61 Polyclonal Antibody
BT-AP15770-100ul 100ul Ask for price
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors.

GPR61 Polyclonal Antibody
BT-AP15770-20ul 20ul Ask for price
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors.

GPR61 Polyclonal Antibody
BT-AP15770-50ul 50ul Ask for price
Description: This gene belongs to the G-protein coupled receptor 1 family. G protein-coupled receptors contain 7 transmembrane domains and transduce extracellular signals through heterotrimeric G proteins. The protein encoded by this gene is most closely related to biogenic amine receptors.

GPR61 Polyclonal Antibody
E44H10138 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

GPR61 Polyclonal Antibody
MBS8531891-01mg 0.1mg
EUR 305

GPR61 Polyclonal Antibody
MBS8531891-01mLAF405L 0.1mL(AF405L)
EUR 465

GPR61 Polyclonal Antibody
MBS8531891-01mLAF405S 0.1mL(AF405S)
EUR 465

GPR61 Polyclonal Antibody
MBS8531891-01mLAF610 0.1mL(AF610)
EUR 465

GPR61 Polyclonal Antibody
MBS8531891-01mLAF635 0.1mL(AF635)
EUR 465

GPR61 Conjugated Antibody
MBS9452885-01mLAF350 0.1mL(AF350)
EUR 480

GPR61 Conjugated Antibody
MBS9452885-01mLAF405 0.1mL(AF405)
EUR 480

GPR61 Conjugated Antibody
MBS9452885-01mLAF488 0.1mL(AF488)
EUR 480

GPR61 Conjugated Antibody
MBS9452885-01mLAF555 0.1mL(AF555)
EUR 480

GPR61 Conjugated Antibody
MBS9452885-01mLBiotin 0.1mL(Biotin)
EUR 480

GPR61 Polyclonal Antibody
UB-GEN-7232 100 ul
EUR 200

GPR61 Rabbit Polyclonal Antibody
ES11477-100ul 100ul
EUR 124
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Rabbit Polyclonal Antibody
ES11477-50ul 50ul
EUR 74
Description: A Rabbit Polyclonal antibody against GPR61 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPR61 Antibody - N-terminal region
MBS3223892-01mL 0.1mL
EUR 455

GPR61 Antibody - N-terminal region
MBS3223892-5x01mL 5x0.1mL
EUR 1995

GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61)
SC317735 10 µg Ask for price

GPR61 (untagged)-Human G protein-coupled receptor 61 (GPR61)
SC106692 10 µg Ask for price

Human GPR61 Protein Lysate
MBS8412523-002mg 0.02mg
EUR 365

Human GPR61 Protein Lysate
MBS8412523-5x002mg 5x0.02mg
EUR 1410

Polyclonal GPR61 Antibody (C-Terminus)
APR16588G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (C-Terminus)
APR16589G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (C-Terminus). This antibody is tested and proven to work in the following applications:

Polyclonal GPR61 Antibody (N-Terminus)
APR16592G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (N-Terminus). This antibody is tested and proven to work in the following applications:

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody
20-abx147479
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody
abx147480-100ug 100 ug
EUR 526.8

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody
abx147479-1096tests 10 × 96 tests Ask for price

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody
abx147479-596tests 5 × 96 tests
EUR 387.5

Probable G-Protein Coupled Receptor 61 (GPR61) Antibody
abx147479-96tests 96 tests
EUR 300

Polyclonal GPR61 Antibody (Cytoplasmic Domain)
APR16590G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

GPR61 Recombinant Protein (Rat)
RP203447 100 ug Ask for price

Polyclonal GPR61 Antibody (Extracellular Domain)
APR16591G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR61 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

GPR61 Recombinant Protein (Human)
RP013882 100 ug Ask for price

GPR61 Recombinant Protein (Mouse)
RP139673 100 ug Ask for price

GPR61 (GFP-tagged) - Human G protein-coupled receptor 61 (GPR61)
RG209672 10 µg Ask for price

Gpr61 (untagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug)
MC216046 10 µg Ask for price

Human GPR61 Protein Lysate 20ug
IHUGPR61PLLY20UG each
EUR 213
Description: Human GPR61 Protein Lysate 20ug

GPR61 Rabbit Polyclonal (N-Terminus) Antibody
TA316841 50 µg Ask for price

GPR61 Rabbit Polyclonal (C-Terminus) Antibody
TA316842 50 µg Ask for price

GPR61 Rabbit Polyclonal (C-Terminus) Antibody
TA316843 50 µg Ask for price

Gpr61 (GFP-tagged) - Mouse G protein-coupled receptor 61 (Gpr61), (10ug)
MG216498 10 µg Ask for price

Gpr61 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 61 (Gpr61)
MR216498 10 µg Ask for price

GPR61 (Myc-DDK-tagged)-Human G protein-coupled receptor 61 (GPR61)
RC209672 10 µg Ask for price

OCOA07698-20UG - GPR61 Protein Lysate
OCOA07698-20UG 20ug
EUR 169

Anti- GPR35 protein Antibody
GWB-3B0BBC 0.05 ml Ask for price

Anti- GPR30 protein Antibody
GWB-55A4AD 0.05 ml Ask for price

Anti- GPR30 protein Antibody
GWB-234F28 0.05 ml Ask for price

 

Malnutrition-inflammation complicated syndrome in dialysis sufferers: causes and penalties.

BACKGROUND

Atherosclerotic heart problems and malnutrition are widely known as main causes of the elevated morbidity and mortality noticed in uremic sufferers. C-reactive protein (CRP), an acute-phase protein, is a predictor of cardiovascular mortality in nonrenal affected person populations. In power renal failure (CRF), the prevalence of an acute-phase response has been related to an elevated mortality.

 

METHODS

 

100 and 9 predialysis sufferers (age 52 +/- 1 years) with terminal CRF (glomerular filtration charge 7 +/- 1 ml/min) have been studied. Through the use of noninvasive B-mode ultrasonography, the cross-sectional carotid intima-media space was calculated, and the presence or absence of carotid plaques was decided.

 

Dietary standing was assessed by subjective world evaluation (SGA), dual-energy x-ray absorptiometry (DXA), serum albumin, serum creatinine, serum urea, and 24-hour urine urea excretion.

The presence of an inflammatory response was assessed by CRP, fibrinogen (N = 46), and tumor necrosis factor-alpha (TNF-alpha; N = 87). Lipid parameters, together with Lp(a) and apo(a)-isoforms, in addition to markers of oxidative stress (autoantibodies in opposition to oxidized low-density lipoprotein and vitamin E), have been additionally decided.

RESULTS

In contrast with wholesome controls, CRF sufferers had an elevated imply carotid intima-media space (18.3 +/- 0.6 vs. 13.2 +/- 0.7 mm2, P < 0.0001) and a better prevalence of carotid plaques (72 vs. 32%, P = 0.001). The prevalence of malnutrition (SGA 2 to 4) was 44%, and 32% of all sufferers had an acute-phase response (CRP>> or = 10 mg/liter).

 

Malnourished sufferers had larger CRP ranges (23 +/- Three vs. 13 +/- 2 mg/liter, P < 0.01), elevated calculated intima-media space (20.2 +/- 0.eight vs. 16.9 +/- 0.7 mm2, P < 0.01) and a better prevalence of carotid plaques (90 vs. 60%, P < 0.0001) in contrast with well-nourished sufferers.

Throughout stepwise multivariate evaluation adjusting for age and gender, vitamin E (P < 0.05) and CRP (P < 0.05) remained related to an elevated intima-media space. The presence of carotid plaques was considerably related to age (P < 0.001), log oxidized low-density lipoprotein (oxLDL; P < 0.01), and small apo(a) isoform dimension (P < 0.05) in a multivariate logistic regression mannequin.

 

CONCLUSIONS

These outcomes point out that the quickly growing atherosclerosis in superior CRF seems to be attributable to a synergism of various mechanisms, similar to malnutrition, irritation, oxidative stress, and genetic parts. Aside from basic danger components, low vitamin E ranges and elevated CRP ranges are related to an elevated intima-media space, whereas small molecular weight apo(a) isoforms and elevated ranges of oxLDL are related to the presence of carotid plaques.

  • Protein-energy malnutrition (PEM) and irritation are widespread and often concurrent in upkeep dialysis sufferers. Many components that seem to result in these 2 situations overlap, as do evaluation instruments and such standards for detecting them as hypoalbuminemia.
  • Each these situations are associated to poor dialysis end result. Low urge for food and a hypercatabolic state are amongst widespread options. PEM in dialysis sufferers has been advised to be secondary to irritation; nonetheless, the proof isn’t conclusive, and an equicausal standing and even reverse causal route is feasible.
  • Therefore, malnutrition-inflammation complicated syndrome (MICS) is an applicable time period. Attainable causes of MICS embody comorbid diseases, oxidative and carbonyl stress, nutrient loss by means of dialysis, anorexia and low nutrient consumption, uremic toxins, decreased clearance of inflammatory cytokines, quantity overload, and dialysis-related components.
  • MICS is believed to be the primary reason behind erythropoietin hyporesponsiveness, excessive charge of cardiovascular atherosclerotic illness, decreased high quality of life, and elevated mortality and hospitalization in dialysis sufferers.
  • As a result of MICS results in a low physique mass index, hypocholesterolemia, hypocreatininemia, and hypohomocysteinemia, a “reverse epidemiology” of cardiovascular dangers can happen in dialysis sufferers.
  • Due to this fact, weight problems, hypercholesterolemia, and elevated blood ranges of creatinine and homocysteine look like protecting and paradoxically related to a greater end result.
  • There isn’t a consensus about tips on how to decide the diploma of severity of MICS or tips on how to handle it. A number of diagnostic instruments and therapy modalities are mentioned. Profitable administration of MICS might ameliorate the cardiovascular epidemic and poor end result in dialysis sufferers.
  • Scientific trials specializing in MICS and its doable causes and penalties are urgently required to enhance poor medical end result in dialysis sufferers.

EBV EBNA1 [GST]
DAG1850 500 ug
EUR 3034.8

EBV EBNA1 Mosaic
ebv-271 100µg
EUR 165
Description: Recombinant Epstein-Barr Virus (HHV-4) EBNA1 Mosaic

EBV EBNA1 antibody
20-EG46 1 mg
EUR 90
Description: Goat polyclonal EBV EBNA1 antibody

EBV EBNA1 antibody
MBS534723-1mg 1mg
EUR 240

Recombinant EBV EBNA1 Protein, His, E.coli-1mg
QP11731-1mg 1mg
EUR 1873.2

Recombinant EBV EBNA1 Protein, His, E.coli-100ug
QP11731-100ug 100ug
EUR 381.6

Recombinant EBV EBNA1 Protein, His, E.coli-500ug
QP11731-500ug 500ug
EUR 1034.4

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-1mg
QP11732-1mg 1mg
EUR 1273.2

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-100ug
QP11732-100ug 100ug
EUR 261.6

Recombinant EBV EBNA1 Mosaic Protein, His, E.coli-500ug
QP11732-500ug 500ug
EUR 795.6

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]
VAng-2528Lsx-100g 100 µg
EUR 555.6
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]
VAng-2528Lsx-1mg 1 mg
EUR 3360
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [His]
VAng-2528Lsx-500g 500 µg
EUR 2040
Description: EBV EBNA1 Mosaic protein, His tag at C-terminus, recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]
VAng-Lsx0111-100g 100 µg
EUR 759.6
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

Recombinant EBV EBNA1 Mosaic Protein (aa 1-90 & 408-498) [GST]
VAng-Lsx0111-500g 500 µg
EUR 2419.2
Description: EBV EBNA1 Mosaic protein [GST], recombinant protein from E. coli.

Recombinant EBV EBNA1 Antigen, His-tagged
VAC-0197 0.5ml
EUR 1598.4
Description: Protein

EBV Nuclear Antigen EBNA1. p72 (stabilized)
BA1362R01 29 mg
EUR 715

Epstein Barr Virus, EBNA1, Recombinant (EBV)
MBS637565-01mg 0.1mg
EUR 845

Epstein Barr Virus, EBNA1, Recombinant (EBV)
MBS637565-5x01mg 5x0.1mg
EUR 3660

Recombinant EBV EBNA1 Mosaic Antigen, His-tagged
VAC-0198 0.5ml
EUR 1598.4
Description: Protein

EBV EBNA protein
30-AE46 200 ug
EUR 667
Description: Purified recombinant EBV EBNA protein

EBV EBNA protein
MBS538336-INQUIRE INQUIRE Ask for price

EBNA1 protein
30-1925 500 ug
EUR 495
Description: Purified Recombinant EBNA1 protein

RECOMBINANT ANTIGEN EBNA1 from Epstein-Barr Virus (EBV)
MBS505053-1mg 1mg
EUR 1080

RECOMBINANT ANTIGEN EBNA1 from Epstein-Barr Virus (EBV)
MBS505053-5x1mg 5x1mg
EUR 4575

Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV)
MBS636498-01mg 0.1mg
EUR 540

Epstein Barr Virus, Nuclear Antigen, EBNA1, Recombinant (EBV)
MBS636498-5x01mg 5x0.1mg
EUR 2275

EBNA1 protein (His tag)
80-1340 100 ug
EUR 233
Description: Purified recombinant EBNA1 protein (His tag)

Recombinant EBNA1 Protein [GST]
VAng-Lsx0122-100g 100 µg
EUR 818.4
Description: EBNA1 (EBV) (P03211) partial recombinant protein with GST tag expressed in E. coli.

Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV)
MBS636094-01mg 0.1mg
EUR 755

Epstein Barr Virus, Nuclear Antigen, Recombinant EBNA1, 27kD CT (EBV)
MBS636094-5x01mg 5x0.1mg
EUR 3170

Purified Recombinant EBNA1 protein
MBS5308620-05mg 0.5mg
EUR 795

Purified Recombinant EBNA1 protein
MBS5308620-5x05mg 5x0.5mg
EUR 3430

EBNA1 Binding Protein 2 Protein
20-abx260778
  • Ask for price
  • Ask for price
  • Ask for price
  • 1 mg
  • 20 ug
  • 5 ug

EBNA1 Binding Protein 2 Protein
abx260778-10g 10 µg
EUR 325

EBNA1 Binding Protein 2 Protein
abx260778-2g 2 µg
EUR 225

Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV)
MBS638308-01mg 0.1mg
EUR 490

Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV)
MBS638308-05mg 0.5mg
EUR 1065

Epstein Barr Virus, Nuclear Antigen, EBNA1, Mosaic, Recombinant (aa1-90, 408-498) (EBV)
MBS638308-5x05mg 5x0.5mg
EUR 4635

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (3D4)
MBS1569155-01mg 0.1mg
EUR 405

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (3D4)
MBS1569155-5x01mg 5x0.1mg
EUR 1520

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2)
MBS1569156-01mg 0.1mg
EUR 405

Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (16D2)
MBS1569156-5x01mg 5x0.1mg
EUR 1520

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
20-abx123650
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx026949-400ul 400 ul
EUR 627.6

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx026949-80l 80 µl
EUR 343.2

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx123650-100l 100 µl
EUR 175

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx123650-1ml 1 ml
EUR 400

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx123650-200l 200 µl
EUR 275

EBNA1 Binding Protein 2 (EBNA1BP2) Antibody
abx026949-400l 400 µl
EUR 518.75

Recombinant (E.Coli, GST tag) Epstein-Barr Virus (EBV/HHV-4) Mosaic EBNA1
RP-347 100 ug
EUR 343.2

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (AP)
MBS6123099-01mL 0.1(mL
EUR 935

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (AP)
MBS6123099-5x01mL 5x0.1mL
EUR 4050

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (PE)
MBS6123103-01mL 0.1(mL
EUR 935

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (PE)
MBS6123103-5x01mL 5x0.1mL
EUR 4050

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (APC)
MBS6123100-01mL 0.1(mL
EUR 935

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (APC)
MBS6123100-5x01mL 5x0.1mL
EUR 4050

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (Biotin)
MBS6123101-01mL 0.1(mL
EUR 935

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (Biotin)
MBS6123101-5x01mL 5x0.1mL
EUR 4050

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (FITC)
MBS6123102-01mL 0.1(mL
EUR 935

EBV Early Antigens (EBNA1, EBV nuclear antigen 1, Epstein Barr nuclear antigen 1, Human Herpesvirus 4 (HHV4)) (FITC)
MBS6123102-5x01mL 5x0.1mL
EUR 4050

Purified recombinant EBNA1 protein (His tag)
MBS5308460-07mg 0.7mg
EUR 1185

Purified recombinant EBNA1 protein (His tag)
MBS5308460-5x07mg 5x0.7mg
EUR 5120

EBNA1BP2 EBNA1 Binding Protein 2 Human Recombinant Protein
PROTQ99848 Regular: 20ug
EUR 380.4
Description: Recombinant Human EBNA1BP2 produced in E. coli is a single polypeptide chain containing 329 amino acids (1-306) and having a molecular mass of 37.2kDa.;EBNA1BP2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Recombinant EBNA1 Protein [His] (1.185 mg/mL)
VAng-0610Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.185 mg/mL.

Recombinant EBNA1 Protein [His] (1.25 mg/mL)
VAng-0611Lsx-inquire inquire Ask for price
Description: Epstein-Barr Virus (EBV) Nuclear Antigen-1 (EBNA-1), recombinant protein from E. coli. MW 63 kDa, 1.25 mg/mL.

Epstein-Barr Virus (HHV-4) EBNA1 Protein
20-abx260340
  • Ask for price
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 100 ug
  • 1 mg

Mouse EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit
abx389130-96tests 96 tests
EUR 1093.2

Human EBNA1 Binding Protein 2 (EBNA1BP2) ELISA Kit
abx384822-96tests 96 tests
EUR 1093.2

Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4)
MBS609692-01mg 0.1mg
EUR 580

Epstein Barr Virus, Nuclear Antigen (Epstein-Barr Nuclear Antigen 1, EBV Nuclear Antigen 1, EBNA1, EBNA-1, EBV, BKRF1, Human Herpes virus 4, HHV4)
MBS609692-5x01mg 5x0.1mg
EUR 2470

EBV EBNA-1, Recombinant
MBS318777-1mg 1mg
EUR 1675

EBV EBNA-1, Recombinant
MBS318777-5x1mg 5x1mg
EUR 7255

EBNA1 Binding Protein 2 Human Recombinant
rAP-5190 Inquiry Ask for price

Recombinant Human EBNA1 Binding Protein 2
MBS145981-0005mg 0.005mg
EUR 240

Recombinant Human EBNA1 Binding Protein 2
MBS145981-002mg 0.02mg
EUR 310

Recombinant Human EBNA1 Binding Protein 2
MBS145981-1mg 1mg
EUR 2880